Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Preoperative Stereotactic Partial Breast Irradiation on Treatment Response, Treatment-related Toxicity, and Cosmetic Outcomes in Early-stage Breast Cancer: A Prospective, Phase II Clinical Trial

NCT06677944 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT06677944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06677944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Preoperative Stereotactic Partial Breast Irradiation on Treatment Response, Treatment-related Toxicity, and Cosmetic Outcomes in Early-stage Breast Cancer: A Prospective, Phase II Clinical Trial
Lead sponsor
Yonsei University
Phase
Phase 2
Overall status
Recruiting
Start date
October 13, 2023
Completion date
October 12, 2026
Enrollment
47 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ductal carcinoma in situ, invasive breast cancer